Suppr超能文献

TRAF2:cIAP2 和 TRAF1:TRAF2:cIAP2 复合物的晶体结构:亲和力、特异性和调节。

Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation.

机构信息

Weill Medical College, Cornell University, New York, NY 10021, USA.

出版信息

Mol Cell. 2010 Apr 9;38(1):101-13. doi: 10.1016/j.molcel.2010.03.009.

Abstract

TRAF1/2 and cIAP1/2 are members of the TNF receptor-associated factor (TRAF) and the inhibitor of apoptosis (IAP) families, respectively. They are critical for canonical and noncanonical NF-kappaB signaling pathways. Here, we report the crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes. A TRAF2 trimer interacts with one cIAP2 both in the crystal and in solution. Two chains of the TRAF2 trimer directly contact cIAP2, and key residues at the interface are confirmed by mutagenesis. TRAF1 and TRAF2 preferentially form the TRAF1: (TRAF2)(2) heterotrimer, which interacts with cIAP2 more strongly than TRAF2 alone. In contrast, TRAF1 alone interacts very weakly with cIAP2. Surprisingly, TRAF1 and one chain of TRAF2 in the TRAF1: (TRAF2)(2): cIAP2 ternary complex mediate interaction with cIAP2. Because TRAF1 is upregulated by many stimuli, it may modulate the interaction of TRAF2 with cIAP1/2, which explains regulatory roles of TRAF1 in TNF signaling.

摘要

TRAF1/2 和 cIAP1/2 分别是肿瘤坏死因子受体相关因子(TRAF)和凋亡抑制蛋白(IAP)家族的成员。它们对于经典和非经典 NF-κB 信号通路至关重要。在这里,我们报告了 TRAF2:cIAP2 和 TRAF1:TRAF2:cIAP2 复合物的晶体结构。在晶体和溶液中,TRAF2 三聚体与一个 cIAP2 相互作用。TRAF2 三聚体的两条链直接与 cIAP2 接触,并且通过突变确认了界面上的关键残基。TRAF1 和 TRAF2 优先形成 TRAF1:(TRAF2)(2)异三聚体,与 cIAP2 的相互作用比 TRAF2 单独与 cIAP2 的相互作用更强。相比之下,TRAF1 单独与 cIAP2 的相互作用非常弱。令人惊讶的是,TRAF1 和 TRAF1:(TRAF2)(2):cIAP2 三元复合物中的 TRAF2 链介导与 cIAP2 的相互作用。由于 TRAF1 被许多刺激物上调,它可能调节 TRAF2 与 cIAP1/2 的相互作用,这解释了 TRAF1 在 TNF 信号中的调节作用。

相似文献

2
Asymmetric recruitment of cIAPs by TRAF2.
J Mol Biol. 2010 Jul 2;400(1):8-15. doi: 10.1016/j.jmb.2010.04.055. Epub 2010 May 4.
3
Comparison of Target Recognition by TRAF1 and TRAF2.
Int J Mol Sci. 2020 Apr 21;21(8):2895. doi: 10.3390/ijms21082895.
4
Molecular basis for TANK recognition by TRAF1 revealed by the crystal structure of TRAF1/TANK complex.
FEBS Lett. 2017 Mar;591(5):810-821. doi: 10.1002/1873-3468.12584. Epub 2017 Feb 17.
5
TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
PLoS Pathog. 2015 May 21;11(5):e1004890. doi: 10.1371/journal.ppat.1004890. eCollection 2015 May.
6
Selective disruption of Traf1/cIAP2 interaction attenuates inflammatory responses and rheumatoid arthritis.
J Autoimmun. 2025 Mar;152:103377. doi: 10.1016/j.jaut.2025.103377. Epub 2025 Feb 5.
7
Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation.
J Biol Chem. 2004 Jan 2;279(1):677-85. doi: 10.1074/jbc.M310969200. Epub 2003 Oct 13.
8
Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2.
Cell Death Differ. 2011 Aug;18(8):1376-86. doi: 10.1038/cdd.2011.10. Epub 2011 Feb 18.
10
The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.
J Biol Chem. 2006 Sep 29;281(39):29022-9. doi: 10.1074/jbc.M605116200. Epub 2006 Aug 4.

引用本文的文献

3
Inflammation and cancer cell survival: TRAF2 as a key player.
Cell Death Dis. 2025 Apr 14;16(1):292. doi: 10.1038/s41419-025-07609-w.
4
TRAF1 promotes osteoclastogenesis by enhancing metabolic adaptation to oxidative phosphorylation in an AKT-dependent manner.
Mol Ther. 2025 Mar 5;33(3):933-949. doi: 10.1016/j.ymthe.2025.01.040. Epub 2025 Jan 25.
5
Exploring TNFR1: from discovery to targeted therapy development.
J Transl Med. 2025 Jan 15;23(1):71. doi: 10.1186/s12967-025-06122-0.
6
CD137-expressing regulatory T cells in cancer and autoimmune diseases.
Mol Ther. 2025 Jan 8;33(1):51-70. doi: 10.1016/j.ymthe.2024.12.010. Epub 2024 Dec 11.
7
TRAF1 from a Structural Perspective.
Biomolecules. 2024 Apr 23;14(5):510. doi: 10.3390/biom14050510.
10
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects.
Sci Adv. 2023 Aug 18;9(33):eadf6692. doi: 10.1126/sciadv.adf6692.

本文引用的文献

2
Structural basis for the lack of E2 interaction in the RING domain of TRAF2.
Biochemistry. 2009 Nov 10;48(44):10558-67. doi: 10.1021/bi901462e.
3
E2 interaction and dimerization in the crystal structure of TRAF6.
Nat Struct Mol Biol. 2009 Jun;16(6):658-66. doi: 10.1038/nsmb.1605. Epub 2009 May 24.
4
Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation.
Cell. 2009 Mar 20;136(6):1098-109. doi: 10.1016/j.cell.2009.03.007.
6
TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
Oncogene. 2009 Apr 2;28(13):1584-93. doi: 10.1038/onc.2009.17. Epub 2009 Feb 23.
9
IAP-targeted therapies for cancer.
Oncogene. 2008 Oct 20;27(48):6252-75. doi: 10.1038/onc.2008.302.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验